New Lab at UF’s Sid Martin Biotech to Pave Way for Post-COVID Therapy, Regenerative Medicine Research
Share Article
Noninvasive cellular and acellular therapies will lead to life-extending medicines and treatments, including post-COVID anti-inflammation therapy. A new partnership between the world’s top university for biotech business incubation and Neobiosis, a global expert in regenerative medicine, may fuel a healthcare revolution.
Regenerative therapy holds the promises of lasting health and wellness through FDA-approved practices.
Regenerative medicine has the potential to fight disease and revolutionize healthcare. The therapies center on treatments that support the body in repairing, regenerating and restoring itself.
Entomologist
Akito Kawahara says, We can’t live without insects. They’re in trouble. And there’s something all of us can do to help.
Kawahara’s research has primarily focused on answering fundamental questions about moth and butterfly evolution, according to a news release from the Florida Museum of Natural History. Kawahara is increasingly haunted by studies that sound the alarm about plummeting insect numbers and diversity.
While scientists differ on the severity of the problem, many findings point to a general downward trend, with one study estimating 40% of insect species are vulnerable to extinction. In response, Kawahara has turned his attention to boosting people’s appreciation for some of the world’s most misunderstood animals.